Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur With Cruciate Sacrificing Inserts
Sponsor: MicroPort Orthopedics Inc.
This observational or N/A phase trial investigates Avascular Necrosis and Correction of Functional Deformity and is currently ongoing. MicroPort Orthopedics Inc. leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Jul 2023 — Apr 2024 [monthly]
Active Not Recruiting
-
Jul 2022 — Jul 2023 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Apr 2022 — Jul 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Apr 2022 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MicroPort Orthopedics Inc.
For direct contact, visit the study record on ClinicalTrials.gov .